4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000050
Chief Medical Officer sold 26,710 shares at an average $14.76 ($394,219)
- Chief Medical Officer acquired 26,710 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-08-02 | Option exercise 10b5-1 | +10,348 | $2.10 | $21,731 | 37,478 | D: show line 1 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-02 | Sale 10b5-1 | −9,280 | $15.09 | $140,013 | 28,198 | D: show line 2 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-02 | Sale 10b5-1 | −1,000 | $16.01 | $16,012 | 27,198 | D: show line 3 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-02 | Sale 10b5-1 | −68 | $16.82 | $1,144 | 27,130 | D: show line 4 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-03 | Option exercise 10b5-1 | +9,464 | $2.10 | $19,874 | 36,594 | D: show line 5 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-03 | Sale 10b5-1 | −9,464 | $14.74 | $139,530 | 27,130 | D: show line 6 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-04 | Option exercise 10b5-1 | +6,898 | $2.10 | $14,486 | 34,028 | D: show line 7 in the form |
| KREHER NERISSA Chief Medical Officer | 2023-08-04 | Sale 10b5-1 | −6,898 | $14.14 | $97,521 | 27,130 | D: show line 8 in the form |
| Open-market sales · 26,710 sh · avg $14.76 · $394,219 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KREHER NERISSA Chief Medical Officer | 2023-08-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,348 | 104,374 | D: show line 9 in the form | ||
| KREHER NERISSA Chief Medical Officer | 2023-08-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,464 | 94,910 | D: show line 10 in the form | ||
| KREHER NERISSA Chief Medical Officer | 2023-08-04 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,898 | 88,012 | D: show line 11 in the form |
Loading xslF345X05/wf-form4_169118219238022.xml…